Aspiration sclerotherapy: a novel and cost-effective approach to the management of hydroceles in a developing country
DOI:
https://doi.org/10.18203/2349-2902.isj20175071Keywords:
Hydrocele, Sodium tetradecyl sulfate, SclerotherapyAbstract
Background: The present study was carried out with an aim to perform a prospective study to establish the role of sodium tetradecyl sulfate (3 %) (STDS) as a safe and effective sclerosant in the management of primary hydroceles.
Methods: Sclerotherapy was performed with 3 % STDS on an outdoor basis. The amount of sclerosant injected depended on the amount of fluid drained. All patients were given prophylactic antibiotics. Patients were clinically reassessed at 1 week, 1 month, 3 months, and 6 months and earlier if complications occurred. All patients were given prophylactic antibiotics. The data were analyzed using Statistical Package for Social Sciences Version 15.0. The data have been represented as frequencies and percentages. Chi-square test was used to compare the data. A total of 57 patients with primary vaginal hydrocele gave consent for being enrolled in the study. The age of patients ranged from 18 to 65 years with a mean age of 35.72±13.18 years.
Results: The success rate at the end of the study was observed to be 84.2 %. As regards patient satisfaction, in present study, in a limited time period of follow up, all the patients who had a successful procedure were satisfied.
Conclusion: Overall, sclerotherapy was observed to be a relatively cost-effective (including both direct and indirect costs) procedure with low complications, high satisfaction, faster return to work and a high success rate within the limited period of follow-up.
Metrics
References
Lord PH. A bloodless operation for the radical cure of idiopathic hydrocoele. Br J Surg. 1969;51:914-916.
Swartz MA, Morgan TM, Krieger JN. Complications of scrotal surgery for benign conditions. Urology. 2007;69:192-3.
Farquharson EL, Rintoul RF. Farquharson’s textbook of operative surgery, 7th Edn. Churchill Livingstone, Edinburgh; 1986.
Albrecht W, Holti W, Aharinejad S. Lord’s procedure- the best operation for hydrocele? Br J Urol. 1991;68(2):187-9.
Das S. A practical guide to operative surgery, 3rd Edn. SD Publishers, 13 Old Mayor's Court, Kolkata. 1992.
Breda G, Giunta A, Gherardi L, Xaysa D, Silvestre P, Tamai A. Treatment of hydrocoele: randomized prospective study of simple aspiration and sclerotherapy with tetracycline. Br J Urol. 1992;70:76-7.
Daehlin L, Tonder B, Kapstad L. Comparison of polidocanol and tetracycline in the sclerotherapy of testicular hydrocele and epididymal cyst. Br J Urol. 1997;80:468-71.
Tammela TL, Hellstrom PA, Matilla SI, Ottelin PJ, Mallinen LJ, Makarainen HP. Ethanolamine oleate sclerotherapy for hydroceles and spermatoceles: a survey of 158 patients with ultrasound follow-up. J Urol. 1992;147:1551-3.
Honnes-de-Lichtenberg M, Miskowiak J, Krogh J. Tetracycline sclerotherapy for hydrocele and epididymal cyst; long term results. Acta Chir Scand. 1990;156(6-7):439-40.
Ullah N, Gondal SH. Sclerotherapy: an acceptable mode of treatment in primary hydrocele. Pak Postgrad Med J. 2001;12(3):111-2.
Andersen M, Bentsen G. Sclerotherapy for spermatocele and hydroceles. Long-term results of polidocanol use. Tidsskr Nor Laegeforen. 1993;113(25):3146-7.
Roosen JU, Larsen T, Iversen B, Birg JB. A comparison of aspiration, antazoline sclerotherapy and surgery in the treatment of hydrocele. Br J Urol. 1991;68(4):404-6.
Yamamoto M, Hibi H, Miyake K. A new sclerosant therapy for testicular hydrocele with aspiration and injection of OKB-432. Int Urol Nephrol. 1994;26(2):205-8.
Stattin P, Karlberg L, Damber JE. Long-term outcome of patients treated for hydrocele with the sclerosant agent sodium tetradecyl sulphate. Scand J Urol Nephrol. 1996;30(2):109-13.
Murtagh J. Hydroceles. Australian Doctor, June 2004. Available at: http://www.australiandoctor.com.au/patient/AD_048___JUN18_04.pdf
Bhumiratana A, Wattanakull B, Koyadun S. Relationship between male hydrocele and infection prevalences in clustered communities with uncertain transmission of Wuchereria bancrofti on the Thailand–Myanmar border. Southeast Asian J Trop Med Public Health. 2001;33(1):7-17.
Latif U, Bashir MA, Rashid A, Rehman QU, Shah TA. Hydrocele: surgery vs sclerotherapy. Professional Med J. 2008;15(1):125-8.
Fuse H, Sakamoto M, Fujisitiro Y, Katayama T. Sclerotherapy of hydroceles with polidocanol. Int Urol Neph. 1994;26(2):199-204.
Agrawal MS, Yadav H, Upadhyay A, Jaiman R, Singhal J, Singh AK. Sclerotherapy for hydrocele revisited: a prospective randomised study. Indian J Surg. 2009;71:23-8.
Jamaluddin M, Alam T, Khan RA, Abbas SM. Results of surgical management of primary vaginal hydrocele in patients of all ages in ASH. Pakistan J Surg. 2009;25(3):190-4.S
Hanif F, Mirza SM, Ali A, Chaudhry AM. Role of sclerotherapy as primary treatment of hydrocele. J Coll Physicians Surg Pak. 2001;11(10):611-3.
Khaniya S, Agrawal CS, Koirala R, Regmi R, Adhikary S. Comparison of aspiration–sclerotherapy with hydrocelectomy in the management of hydrocele: a prospective randomized study. Int J Surg. 2009;7(4):392-5.
Rencken RK, Bornman MS, Reif S, Olivier I. Sclerotherapy for hydroceles. J Urol. 1990;143(5):940-3.
Beiko DT, Kim D, Morales A. Aspiration and sclerotherapy versus hydrocelectomy for treatment of hydroceles. Urology. 2003;61(4):708-12.
Brasilis KG, Moss DIM. Long-term experience with sclerotherapy for treatment of epididymal cyst and hydrocele. ANZ J Surg. 1996;66(4):222-4.
Latif U, Bashir MA, Rashid A, Rehman QU, Shah TA. Hydrocele: surgery vs sclerotherapy. Professional Med J. 2008;15(1):125-8.
Rencken RK, Bornman MS, Reif S. Sclerotherapy for hydroceles. J Urol. 1990;143:940-3.
Brasilis KG, Moss DL. Treatment modalities of benign scrotal swellings. Aust N Z J Surg. 1990;66(9):222-9.
Erdas E, Pisano G, Pomata M, Pinna G, Secci L, Licheri S, Daniele GM. Sclerotherapy and hydrocelectomy for the management of hydrocele in outpatient and day-surgery setting. Chirurgia italiana. 2005 Dec;58(5):619-25.
Downloads
Published
How to Cite
Issue
Section
